Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania. (Q64360290)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania. |
scientific article |
Statements
1 reference
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania. (English)
1 reference
Pontiano Kaleebu
1 reference
Zacchaeus Anywaine
1 reference
Hilary Whitworth
1 reference
George Praygod
1 reference
Georgi Shukarev
1 reference
Daniela Manno
1 reference
Saidi Kapiga
1 reference
Samuel Kalluvya
1 reference
Viki Bockstal
1 reference
Dickson Anumendem
1 reference
Kerstin Luhn
1 reference
Cynthia Robinson
1 reference
Macaya Douoguih
1 reference
Deborah Watson-Jones
1 reference
1 June 2019
1 reference
220
1 reference
1
1 reference
46-56
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference